Skip to content
AnthologyRX

BPC-157

Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.

Your treatment plan

From $179/month

$537 billed every 3 months3-month commitmentView plan details
  • Licensed clinicians
  • Compounded by a licensed 503A pharmacy
  • No clinic visit

Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.

What It Is

Repair needs a way in.

Tendons and ligaments are difficult tissue to rebuild. Their limited blood supply means the cells, oxygen, and raw materials involved in repair have a harder time reaching the place they are needed.

BPC-157 is built around that problem.

It is a synthetic 15-amino-acid peptide modeled on a naturally occurring protective protein found in the stomach lining, one of the most demanding repair environments in the body. Researchers isolated the sequence now known as BPC-157 and have studied how it interacts with several parts of the tissue-repair process.

The findings are what made this peptide famous.

Research shows BPC-157 promotes new blood-vessel growth through VEGFR2, a signaling pathway your body uses in angiogenesis.1 In rat tendon and cultured tendon cells, BPC-157 increased the outgrowth, survival, and migration of the cells involved in rebuilding damaged tissue.2

That matters because repair is not one event. Tissue needs blood supply. Repair cells need to reach the site. And the environment has to support the work once they get there.

BPC-157 is one of the most studied and most requested peptides in the recovery conversation for a reason.

If you already know the molecule, the meaningful difference is what surrounds it: a licensed clinician, a licensed US pharmacy, and an individual prescription. Potential benefits stay tied to the research that reported them.

  1. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with… J Mol Med. 2017.
  2. Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing… J Appl Physiol. 2011.
Who It's For

For the injuries that are technically over, but not forgotten.

01

The Accumulated Wear

Nothing is torn. Nothing is broken. But years of training, compensation, and small injuries have left connective tissue that keeps asking for more attention than the rest of you.

02

The Recovery That Plateaued

You did the rehab. You gave it time. Most of the progress came, and then the last part simply stopped moving. You know the difference between discomfort and a recovery that has stalled.

03

Cleared Is Not the Same as Rebuilt

The procedure is behind you and the surgeon has signed off. Now the work is about the tissue you still have to live, train, and move with every day.

Compounded BPC-157 is not an FDA-approved drug product. Whether it is appropriate for you is determined by a licensed provider from your full Assessment.

This might not be the right fit if:
  • Active or suspected malignancy, or a history of cancer without oncology clearance
  • Pregnancy or breastfeeding
  • Known hypersensitivity to any component of the preparation
  • Under 18

Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.

Your Plan

BPC-157, prescribed with care.

Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.

One price covers the provider, the prescription if approved, the pharmacy, and the follow-up.
Important Safety Information

Do not use if you have

  • Active or suspected malignancy

Commonly reported

  • Mostly local — soreness, redness or swelling where you inject

Because BPC-157 acts on blood vessel formation, your provider screens carefully for any history of cancer. Human safety data is limited, which is the reason this sits with a clinician rather than in a shopping cart.

Questions

Asked and answered.

If your provider determines you are not a candidate for any available treatment, any consultation fee paid will be refunded within 7–10 business days. You are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.

In July 2026 an FDA advisory committee voted to recommend BPC-157 for pharmacy compounding. That recommendation is advisory and the agency has not yet acted on it. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.

The honest answer depends on the tissue, the injury, and you. Your provider sets expectations from your history and adjusts the plan from what actually happens rather than promising a recovery calendar before treatment starts.

The difference is not the name on the vial. It is everything around it. Research chemicals are sold without a clinician deciding whether the compound belongs in your care, without a prescription prepared for you by a licensed pharmacy, and without a medical record connecting the medication to the person taking it. The FDA has found products sold this way under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. With AnthologyRX, a licensed provider reviews your history and a licensed US pharmacy fills your prescription. You are buying medical care around an interesting molecule, not a vial and a disclaimer.

Any time, before your renewal date. No phone calls required.

  1. FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, and FDA Warning Letter to Gram Peptides, March 31, 2026.
Explore

More in Performance & Recovery.

AnthologyRX
Find your treatment
Browse all treatments